Zyprexa News
Most Popular Zyprexa Story
Lilly adding ethics watchdogs to executive ranks
Four new ethics watchdogs will join Eli Lilly as part of a deal to settle two shareholder lawsuits over the mismarketing of Zyprexa and other drugs. The suits arose after Lilly inked a deal last year... Read more...
Latest Headlines
- March 9, 2010
- February 1, 2010
- December 15, 2009
- December 7, 2009
- December 3, 2009
- October 28, 2009
- September 29, 2009
- July 23, 2009
- June 12, 2009
- June 10, 2009
- March 23, 2009
- January 22, 2009
- January 15, 2009
- January 8, 2009
- November 24, 2008
- November 17, 2008
- October 22, 2008
- October 7, 2008
- September 8, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
